Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): Week-end 'high' followed by mid-week low

Addiction

Volumn 92, Issue 7, 1997, Pages 821-831

  Curran, H Valerie ^a   Travill, Ross A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; SEROTONIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; DRUG EFFECT; FEMALE; HUMAN; MALE; MOOD; NEUROTOXICITY; PSYCHOLOGICAL ASPECT; WORKING MEMORY;

ADULT; AFFECT; ALCOHOL DRINKING; COGNITION; FEMALE; FOLLOW-UP STUDIES; HALLUCINOGENS; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 0030741356     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.1997.tb02951.x     Document Type: Article

References (23)

1. ALLEN R. P., McCANN, U. D. & RICAURTE, G. A. (1993) Persistent effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') on human sleep, Sleep, 16, 560-564.
2. BARNES, D. M. (1988) New data intensifies the agony over Ecstasy, Science, 239, 864-866.
3. BECK, A. T. (1978) The Beck Depression Inventory (BDI) (The Psychological Corporation Harcourt Brace Jovanovitz Inc., USA).
4. BOND, A. J. & LADER, M. H. (1974) The use of analogue scales in rating subjective feelings, British Journal of Medical Psychology, 47, 211-218.
5. CURRAN, H. V. & KOPELMAN, M. D. (1996) The cognitive psychopharmacology of Alzheimer's Disease, in: R. G. M. MORRIS (Ed.) The Cognitive Neuropsychology of Alzheimer's Disease, pp. 255-277 (Oxford, Oxford University Press).
6. DOWNING, J. (1986) The psychological and physiological effects of MDMA on normal volunteers, Journal of Psychoactive Drugs, 18, 335-340.
7. ELKIN, I. (1994) The NIMH treatment of depression collaborative research programme: where we began and where we are, in: BERGIN, A. E. & GARFIELD, S. L. (Eds) Handbook of Psychotherapy and Behaviour Change, pp. 114-119 (New York, Wiley).
8. FINNIGAN, F. & HAMMERSLEY, R. (1992) The effects of alcohol on performance, in: SMITH, A. & JONES, D. M. (Eds) Handbook of Human Performance, pp. 73-126 (London, Academic Press).
9. GREEN, A. R., CROSS, A. J. & GOODWIN, G. M. (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy'), Psychopharmacology, 119, 247-260.
10. GREER, G. & TALBOT, P. (1986) Subjective reports of the effects of MDMA in a clinical setting, Journal of Psychoactive Drugs, 18, 319-327.
11. KRYSTAL, H. & PRICE, L. H. (1992) Chronic MDMA use: effects on mood and neuropsychological function?, American Journal of Drug and Alcohol Abuse, 18, 331-341.
12. LIESTER, M. B., GROB, C. S., BRAVO, G. L. & WALSH, R. N. (1992) Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use, Journal of Nervous and Mental Disorders, 180, 345-352.
13. McGUIRE, P. K., COPE, H. & FAHY, T. A. (1994) Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy'), British Journal of Psychiatry, 165, 391-395.
14. PEROUTKA, S. J. (1987) Incidence of recreational use of 3,4-methylenedioxymethamphetamine (MDMA 'Ecstasy') on an undergraduate campus, New England Journal of Medicine, 317, 1542-1543.
15. PEROUTKA, S. J., NEWMAN, H. & HARRIS, H. (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users, Neuropsychopharmacology, 1, 273-277.
16. RICAURTE, G. A., MARTELLO, A. L., KATZ, J. L. & MARTELLO, M. B. (1992) Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations, Journal of Pharmacology and Experimental Therapeutics, 261, 616-622.
17. SAUNDERS, N. (1995) Ecstasy and the Dance Culture (London, Neal's Yard Desktop Publishing).
18. SCHMIDT, C. J. (1987) Neurotoxicity of the psychedelic amphetamine methylenedioxymethamphetamine, Journal of Pharmacology and Experimental Therapeutics, 240, 1-7.
19. SHAPIRO, D. A., BARKHAM, N., REES, A., HARDY, G. E., REYNOLDS, S. & STARTUP, M. (1994) Effects of treatment duration and severity of depression on the effectiveness of cognitive/behavioural and psychodynamic/interpersonal psychotherapy, Journal of Consulting and Clinical Psychology, 62, 522-534.
20. SOLOWIJ, N., HALL, W. & LEE, N. (1992) Recreational MDMA use in Sydney: a profile of 'Ecstasy' users and their experiences with the drug, British Journal of Addiction, 87, 1161-1172.
21. STEELE, T. D., McCANN, U. D. & RICAURTE, G. A. (1994) 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and toxicology in animals and humans, Addiction, 89, 539-551.
22. WILSON, B., COCKBURN, J. & BADDELEY, A. (1985) The Rivermead Behavioural Memory Test (Reading, UK, Thames Valley Text Co.).
23. YAAMAMOTO, B. & SPANOS, L. (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat, European Journal of Pharmacology, 148, 195-203.